Results 21 to 30 of about 749,006 (236)

Diagnostic Value of CK19, HBME-1 and TROP2 Biomarkers in Identification of Different Types of Thyroid Follicular Neoplasms

open access: yesActa Medica Iranica, 2021
Thyroid malignancies are found in 7% to 15% of all thyroid nodules. Immunohistochemical markers, including CK19, HBME-1and TROP2, have shown an effective role in identifying these malignancies.
Masoud Mohebbi   +4 more
doaj   +1 more source

Concomitant bilateral papillary thyroid carcinoma and parathyroid adenoma

open access: yesCase Reports in Clinical Practice, 2022
Thyroid malignant neoplasms are the most prevalent cancer of the endocrine system, and their concurrence with parathyroid neoplasms is extremely rare.
Reza Hajebi   +2 more
doaj   +1 more source

New biomarkers: prospect for diagnosis and monitoring of thyroid disease

open access: yesFrontiers in Endocrinology, 2023
After the metabolic syndrome and its components, thyroid disorders represent the most common endocrine disorders, with increasing prevalence in the last two decades.
Mirjana T. Macvanin   +7 more
doaj   +1 more source

Diagnostic role of immunohistochemical markers CK19 and CD56 in thyroid neoplasms

open access: yesMGM Journal of Medical Sciences, 2023
Introduction: Thyroid cancer is the most common type of endocrine cancer, with an increasing prevalence. The possibility of a malignant neoplasm is the primary concern in people with thyroid nodules. The presence of a plethora of variants complicates the
Pallavi Priyadarshini   +2 more
doaj   +1 more source

Morphological features of thyroid benign focal neoplasms in Graves’ disease

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2022
Background. The morphology of the thyroid in Graves’ disease (GD) can be quite diverse: in most cases there is a diffuse enlargement of the thyroid gland (diffuse goiter), in some cases it is not increased, and in some patients there are focal neoplasms (
Yu.V. Buldygina   +5 more
doaj   +1 more source

Combined Cyclin D2 and Protein Convertase 2 Genes in Differentiating Various Follicularpatterned Lesions and Neoplasms of the Thyroid: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: A pretherapeutic distinction between benign and malignant thyroid nodules is critical for the clinical management of patients presenting with thyroid nodules.
Prasanna Venkadesa Perumal   +4 more
doaj   +1 more source

Performance of current ultrasound-based malignancy risk stratification systems for thyroid nodules in patients with follicular neoplasms

open access: yesEuropean Radiology, 2022
To investigate the ability of the currently used ultrasound-based malignancy risk stratification systems for thyroid neoplasms (ATA, AACE/ACE/AME, K-TIRADS, EU-TIRADS, ACR-TIRADS and C-TIRADS) in distinguishing follicular thyroid carcinoma (FTC) from ...
Yinghe Lin   +7 more
semanticscholar   +1 more source

Study of nuclear morphometry in the cytologic evaluation of thyroid neoplasms

open access: yesJournal of Pathology of Nepal, 2023
Background: Nuclear morphometry is purported to allow better differentiation between various thyroid lesions beyond what is offered by conventional cytology.
Joyce Thomas   +2 more
doaj   +1 more source

The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: A meta-analysis. [PDF]

open access: yesPLoS One, 2019
Objective We conducted this meta-analysis to assess the effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms. Methods We conducted a search by using PubMed, Embase, and the
Wang B, Zhu CR, Liu H, Wu J.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy